Skip to content

Research library / Survey

Psychedelics and mental health: a population study

Krebs TS, Johansen PØ. PLoS ONE 2013;8(8):e63972

SurveyLSDPsilocybinMescalinegeneral populationmental health

This analysis used a large, nationally representative US survey of more than 130,000 adults to test whether people who have ever used psychedelics have more mental health problems. About one in seven reported ever using LSD, psilocybin, mescaline or peyote. After adjusting for factors such as other drug use, risk-taking and trauma, the authors found no link between psychedelic use and psychological distress, mental health treatment, or symptoms of eight psychiatric disorders including psychosis. In some cases users had lower rates of problems. Because the data are a single snapshot of self-reports, the study cannot show that psychedelics protect mental health, and it may miss rare serious reactions. Its main finding is the absence of a population-level link to harm.

What it found

  • 21,967 respondents (13.4% weighted) reported ever using a psychedelic
  • Lifetime use of any psychedelic, or of LSD, psilocybin, mescaline or peyote specifically, was not associated with higher rates of any of the mental health outcomes studied
  • In several cases psychedelic use was associated with lower rates of mental health problems
Read the paper (free full text)

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.